FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588895035> ?p ?o ?g. }

• W2588895035 endingPage "e0171676" @default.
• W2588895035 startingPage "e0171676" @default.
• W2588895035 abstract "Background The function of the tumor suppressor gene RASSF1A in cancer cells has been detailed in many studies. However, due to the methylation of its promoter, the expression of RASSF1A is missing in most cancers. In the literature, we found that the conclusion regarding the relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma was not unified. This study adopts the use of a meta-analysis and bioinformatics to explore the relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma. Methods Data on melanoma susceptibility were downloaded from the PubMed, Cochrane Library, Web of Science and Google Scholar databases, which were analyzed via a meta-analysis. The effect sizes were estimated by measuring an odds ratio (OR) with a 95% confidence interval (CI). We also used a chi-squared-based Q test to examine the between-study heterogeneity, and used funnel plots to evaluate publication bias. The data on melanoma prognosis, which were analyzed by bioinformatics methods, were downloaded from The Cancer Genome Atlas (TCGA) project. The effect sizes were estimated by measuring the hazard ratios (HRs) with a 95% confidence interval (CI). Results Our meta-analysis included 10 articles. We found that RASSF1A gene promoter methylation was closely related to melanoma susceptibility (OR = 12.67, 95% CI: 6.16 ∼ 26.05, z = 6.90, P<0.0001 according to a fixed effects model and OR = 9.25, 95% CI: 4.37 ∼ 19.54, z = 5.82, P<0.0001 according to a random effects model). The results of the meta-analysis did not reveal any heterogeneity (tau2 = 0.00; H = 1 [1; 1.55]; I2 = 0% [0%; 58.6%], P = 0.5158) or publication bias (t = 0.87, P = 0.4073 by Egger’s test; Z = 0.45, P = 0.6547 by Begg’s test); therefore, we believe that the results of our meta-analysis were more reliable. To explore the relationship between RASSF1A gene methylation, the prognosis of melanoma and the clinical features of this cancer type, we used the melanoma DNA methylation data and clinical data from TCGA project. We found that RASSF1A gene promoter methylation and melanoma prognosis did not demonstrate any relationship (HR was 0.94 (95% CI = [0.69; 1.27], P = 0.694) with disease-free survival and 0.74 (95% CI = [0.53; 1.05], P = 0.106) for overall survival), and no significant difference was observed between RASSF1A gene promoter methylation and the clinical-pathological features of melanoma. Conclusions In conclusion, the meta-analysis of the data in these articles provides strong evidence that the methylation status of the RASSF1A gene promoter was strongly related to melanoma susceptibility. Our bioinformatics analysis revealed no significant difference between RASSF1A gene promoter methylation and the prognosis and clinical-pathological features of melanoma." @default.
• W2588895035 created "2017-02-24" @default.
• W2588895035 creator A5009374491 @default.
• W2588895035 creator A5030813006 @default.
• W2588895035 creator A5040046800 @default.
• W2588895035 creator A5045477206 @default.
• W2588895035 creator A5058259187 @default.
• W2588895035 creator A5061994033 @default.
• W2588895035 creator A5078213165 @default.
• W2588895035 date "2017-02-16" @default.
• W2588895035 modified "2023-10-15" @default.
• W2588895035 title "The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics" @default.
• W2588895035 cites W1504197144 @default.
• W2588895035 cites W1539978227 @default.
• W2588895035 cites W1712387145 @default.
• W2588895035 cites W1886848895 @default.
• W2588895035 cites W1963822275 @default.
• W2588895035 cites W1964435302 @default.
• W2588895035 cites W1966598245 @default.
• W2588895035 cites W1978620346 @default.
• W2588895035 cites W1984710781 @default.
• W2588895035 cites W1990396479 @default.
• W2588895035 cites W1994846170 @default.
• W2588895035 cites W1998107133 @default.
• W2588895035 cites W2014432992 @default.
• W2588895035 cites W2030929478 @default.
• W2588895035 cites W2045553710 @default.
• W2588895035 cites W2051149841 @default.
• W2588895035 cites W2054699746 @default.
• W2588895035 cites W2066074044 @default.
• W2588895035 cites W2092641158 @default.
• W2588895035 cites W2107076128 @default.
• W2588895035 cites W2107328434 @default.
• W2588895035 cites W2108281054 @default.
• W2588895035 cites W2113459016 @default.
• W2588895035 cites W2125435699 @default.
• W2588895035 cites W2126153567 @default.
• W2588895035 cites W2139180993 @default.
• W2588895035 cites W2149071620 @default.
• W2588895035 cites W2150000105 @default.
• W2588895035 cites W2157823046 @default.
• W2588895035 cites W2168713302 @default.
• W2588895035 cites W2169006371 @default.
• W2588895035 cites W2235523093 @default.
• W2588895035 cites W2272984102 @default.
• W2588895035 cites W2330601930 @default.
• W2588895035 cites W2770149957 @default.
• W2588895035 doi "https://doi.org/10.1371/journal.pone.0171676" @default.
• W2588895035 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5312935" @default.
• W2588895035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28207831" @default.
• W2588895035 hasPublicationYear "2017" @default.
• W2588895035 type Work @default.
• W2588895035 sameAs 2588895035 @default.
• W2588895035 citedByCount "12" @default.
• W2588895035 countsByYear W25888950352017 @default.
• W2588895035 countsByYear W25888950352018 @default.
• W2588895035 countsByYear W25888950352019 @default.
• W2588895035 countsByYear W25888950352020 @default.
• W2588895035 countsByYear W25888950352021 @default.
• W2588895035 countsByYear W25888950352023 @default.
• W2588895035 crossrefType "journal-article" @default.
• W2588895035 hasAuthorship W2588895035A5009374491 @default.
• W2588895035 hasAuthorship W2588895035A5030813006 @default.
• W2588895035 hasAuthorship W2588895035A5040046800 @default.
• W2588895035 hasAuthorship W2588895035A5045477206 @default.
• W2588895035 hasAuthorship W2588895035A5058259187 @default.
• W2588895035 hasAuthorship W2588895035A5061994033 @default.
• W2588895035 hasAuthorship W2588895035A5078213165 @default.
• W2588895035 hasBestOaLocation W25888950351 @default.
• W2588895035 hasConcept C101762097 @default.
• W2588895035 hasConcept C104317684 @default.
• W2588895035 hasConcept C126322002 @default.
• W2588895035 hasConcept C143998085 @default.
• W2588895035 hasConcept C150194340 @default.
• W2588895035 hasConcept C156957248 @default.
• W2588895035 hasConcept C190727270 @default.
• W2588895035 hasConcept C207103383 @default.
• W2588895035 hasConcept C2776478404 @default.
• W2588895035 hasConcept C2777658100 @default.
• W2588895035 hasConcept C2780439572 @default.
• W2588895035 hasConcept C33288867 @default.
• W2588895035 hasConcept C44249647 @default.
• W2588895035 hasConcept C54355233 @default.
• W2588895035 hasConcept C60644358 @default.
• W2588895035 hasConcept C71924100 @default.
• W2588895035 hasConcept C82605166 @default.
• W2588895035 hasConcept C86803240 @default.
• W2588895035 hasConcept C95190672 @default.
• W2588895035 hasConceptScore W2588895035C101762097 @default.
• W2588895035 hasConceptScore W2588895035C104317684 @default.
• W2588895035 hasConceptScore W2588895035C126322002 @default.
• W2588895035 hasConceptScore W2588895035C143998085 @default.
• W2588895035 hasConceptScore W2588895035C150194340 @default.
• W2588895035 hasConceptScore W2588895035C156957248 @default.
• W2588895035 hasConceptScore W2588895035C190727270 @default.
• W2588895035 hasConceptScore W2588895035C207103383 @default.
• W2588895035 hasConceptScore W2588895035C2776478404 @default.
• W2588895035 hasConceptScore W2588895035C2777658100 @default.

• next